Bionano Genomics (BNGO) Current Taxes (2024 - 2026)

Bionano Genomics' (BNGO) quarterly Current Taxes came in at $197000.0 in Q1 2026, down 27.57% quarter-over-quarter from $272000.0 in Q4 2025.

Bionano Genomics (BNGO) Current Taxes (2024 - 2026) Analysis & Trends

Bionano Genomics has disclosed Current Taxes across 3 years of filings, most recently posting $197000.0 for Q1 2026.

  • Current Taxes for Q1 2026 came in at $197000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $197000.0 (changed N/A YoY), and the FY2025 annual result was $272000.0, down 62.69% from the prior year.
  • Current Taxes came in at $197000.0 for Q1 2026 at Bionano Genomics, down from $272000.0 in the prior quarter.
  • In the past five years, Current Taxes ranged from a high of $729000.0 in Q4 2024 to a low of $197000.0 in Q1 2026.
  • The 3-year median for Current Taxes is $272000.0 (2025), against an average of $399333.3.
  • Peak annual rise in Current Taxes reached 62.69% in 2025, while the deepest fall reached 62.69% in 2025.
  • Bionano Genomics' Current Taxes stood at $729000.0 in 2024, then tumbled by 62.69% to $272000.0 in 2025, then declined by 27.57% to $197000.0 in 2026.
  • The last three Current Taxes figures came in at $197000.0 (Q1 2026), $272000.0 (Q4 2025), and $729000.0 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Taxes (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn -
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn -
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn -
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn 163.32 Mn
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn 78.90 Mn
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn -
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn -
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn -
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn -
10 Bionano Genomics 14.01 Mn -366,620.40 3.25 Mn 197,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 197,000.00
Dec 31, 2025 272,000.00
Dec 31, 2024 729,000.00